Eprocliv 50 mg/850 mg filmom obložene tablete
| Name | Eprocliv 50 mg/850 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-820207649 |
| Active Substance | sitagliptinklorid hidrat metforminklorid |
| Composition | jedna filmom obložena tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina i 850 mg metforminklorida |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Lek d.d., Lendava, Slovenija Lek S.A., Strykow, Poljska |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 09.02.2021 |
| MA Period of Validity | 09.02.2026 |
| Classification Number | UP/I-530-09/19-01/207 |
| Registration Number | 381-12-01/154-21-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD07 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
